Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy.
BACKGROUND
Complement activation is thought to be pathologically important in IgA nephropathy (IgAN). Although C3 deposition in the mesangium is found in IgAN, the origin of C3 is not clear. We recently demonstrated intraglomerular C3 synthesis in the human kidney; however, the activation and pathological role of locally synthesized C3 remains unclear. Here we performed nonradioactive in situ hybridization for C3 mRNA and immunohistochemistry for C3 and its activation products, such as C3d and membrane attack complex (MAC), to determine whether locally produced C3 in glomeruli was activated in IgA nephropathy.


METHODS
Renal samples from 14 patients with IgAN and 5 with minimal change nephrotic syndrome (MCNS) were examined. Uninvolved portions of surgically removed kidneys with tumors served as normal controls.


RESULTS
C3 mRNA was not detected in glomeruli in control tissue and MCNS, but was strongly expressed in resident glomerular cells of IgAN, including mesangial cells, glomerular epithelial cells and the cells of Bowman's capsule. Examination of serial sections disclosed that more than 70% of cells positive for C3 mRNA were also stained for C3 protein, C3d, and MAC. Double staining for in situ hybridization and immunohistochemistry also revealed that those C3 mRNA signals were present in intraglomerular cells positive for C3. The expression of C3 mRNA and MAC in glomeruli correlated significantly with the degree of mesangial matrix expansion.


CONCLUSIONS
Our results demonstrated that locally synthesized C3 is activated in the glomeruli of IgAN and that its expression correlated with the severity of mesangial matrix expansion. These findings suggest that activation of C3 may be involved in tissue injury in IgAN through the formation of membrane attack complex.
Abe
K
K
Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1, Sakamoto, Nagasaki 852-5201, Japan.
Miyazaki
M
M
Koji
T
T
Furusu
A
A
Shioshita
K
K
Tsukasaki
S
S
Ozono
Y
Y
Harada
T
T
Sakai
H
H
Kohno
S
S
D000293:Adolescent; D000328:Adult; D001706:Biopsy; D003167:Complement Activation / Q000502:physiology; D003176:Complement C3 / Q000032:analysis / Q000096:biosynthesis*; D015933:Complement C3d / Q000032:analysis / Q000096:biosynthesis*; D015938:Complement Membrane Attack Complex / Q000032:analysis / Q000096:biosynthesis*; D005260:Female; D005922:Glomerulonephritis, IGA / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007678:Kidney Glomerulus / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009402:Nephrosis, Lipoid / Q000276:immunology; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism
D003176:Complement C3; D015938:Complement Membrane Attack Complex; D012333:RNA, Messenger; D015933:Complement C3d